Akouos

Akouos Overview

Founded 2016
Founded
Status Public
Employees 57
Employees
Stock Symbol AKUS
Stock Symbol

Akouos General Information

Description

Operator of a biotechnology drug research company intended to develop gene therapies for impaired audio treatment. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 645 Summer Street
  • Suite 200
  • Boston, MA 02210
  • United States
+1 (857) 000-0000

Akouos Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Akouos Financials Summary

In Thousands,
USD
TTM 31-Dec-2019 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Akouos Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Akouos‘s full profile, request access.

Request a free trial

Akouos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Akouos‘s full profile, request access.

Request a free trial

Akouos Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Decibel Therapeutics Venture Capital-Backed Boston, MA 00000 0000000000 0 00000
000000000 00000000 Formerly VC-backed Woburn, MA 00 00000 00000000 00000
0000000 0000000000 Accelerator/Incubator Backed Alachua, FL 00000 000000000000 00000
000000 00000000000 Venture Capital-Backed Amsterdam, Netherlands 00.000 00000000000 00.000
000000000 Venture Capital-Backed Gaithersburg, MD 00 000.00 00000000000 000.00

Akouos Executive Team (10)

Name Title Board Seat Contact Info
Emmanuel Simons Ph.D Co-Founder, President, Chief Executive Officer and Board Member
Rabia Ozden MD Chief Development Officer
Gregory Robinson Ph.D Chief Scientific Officer
William Sewell Ph.D Co-Founder and Scientific Advisory Board Member
Morgan Molloy Chief Corporate Development Officer

Akouos Board Members (9)

To view Akouos‘s full board member team, request access »
Name Representing Role Since
Arthur Tzianabos Ph.D Self Board Member 000 0000
Christopher Smith Self Board Member 000 0000
Edward Mathers New Enterprise Associates Board Member 000 0000
Emmanuel Simons Ph.D Akouos Co-Founder, President, Chief Executive Officer and Board Member 000 0000
Heather Preston MD Self Board Member 000 0000

Akouos Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Akouos‘s full profile, request access.

Request a free trial